Shanghai United Cell Biotechnology Co., Ltd.

Shanghai United Cell Biotechnology Co., Ltd.

制药业

Empowering Biotech Advancements: leading in R&D, production & expansion of genetically engineered vaccines. 🌐🔬

关于我们

Welcome to Shanghai United Cell Biotechnology Co., Ltd. (SUCB), a high-tech enterprise founded in 1995 by Unilab Inc. and currently affiliated with Brilliance Group. Hillhouse Capital is our major investor. Based in the Jinqiao Biotechnology Industrial Park of Shanghai Pilot Free Trade Zone, SUCB is dedicated to R&D, production, and marketing of genetically engineered vaccines and therapeutic biological products. In 2022, SUCB was recognized as a "Specialized, special, and new enterprise" in Shanghai, boasting a registered capital of $61.15 million. Our state-of-the-art factory spans 20,000 square meters, with an annual production capacity including 15 million freeze-dried powder injections, 13 million cartridge injections, 9 million capsules, and 5.6 million bags of granule preparations. To meet growing demand, SUCB expanded its operations to the Zhuhai High-tech Industrial Development Zone in 2015, establishing Zhuhai United Cell Biotechnology Co., Ltd. (ZUCB). With a registered capital of RMB 50 million, ZUCB operates from the Science and Technology Innovation Coast of the Zhuhai High-tech Zone. Leveraging our 20-year-strong multinational network, SUCB aims to propel China's biotechnology products onto the international stage. We are committed to fostering opportunities and resources for the globalization of China's biotechnology industry. Join us in advancing innovation and excellence in biotechnology!

网站
https://www.unitedbiotech.com.cn/en/aboutus
所属行业
制药业
规模
501-1,000 人
总部
Shanghai
类型
私人持股
创立
1995
领域
Biotech、Pharma、Pharmaceutical、Biotechnology、BiotechInnovation、Vaccines、Medicine和Healthcare

地点

  • 主要

    1150 Guiqiao Road,China(Shanghai) Pilot Free Trade Zone

    CN,Shanghai,201206

    获取路线

动态

相似主页